MULTAQ Associated With Heart and Liver Problems

Introduction: If you or a loved one has suffered injuries including heart failure, heart attack, stroke, systemic embolism, liver damage or liver failure, which you believe may have resulted from Multaq, you may have a legal claim for your injury or loved one’s injury or death. Although our lawyers who handle Multaq lawsuits are located in Maryland (MD), Virginia (VA) and Washington, D.C. (DC), we represent injured clients in complex drug litigation and medical product liability lawsuits across the country. Therefore, regardless of what state you’re from, please fill out the “Contact Us” form on the left side of this page or email us so that Ashcraft & Gerel, LLP can have a lawyer familiar with the Multaq litigation contact you to discuss your potential claim.

Multaq, also known as dronedarone, is a drug manufactured by Sanofi-Aventis that is prescribed to treat persons with cardiac arrhythmia, or irregular heartbeat. Multaq was approved by the FDA in July, 2009 to reduce the risk of cardiovascular hospitalization in patients who have episodes of irregular heart rhythms. Even before the drug was approved by the FDA, questions were raised regarding Multaq’s safety. A 2005 clinical trial showed that Multaq doubled the risk of death and could actually worsen existing heart failure. A November 2010 report published by the non-profit Institute for Safe Medication Practices described a number of other injuries associated with the use of Multaq, including both liver damage and heart complications involving left ventricle dysfunction and ventricular tachycardia. In January, 2011 the FDA mandated that a warning be added to Multaq’s label after Sanofi-Aventis reported that two patients on the drug experienced liver failure. Most recently, an FDA Safety Announcement of July 21, 2011 warned that Multaq may increase the incidence of several cardiovascular problems including heart failure, heart attack, stroke and systemic embolism.

If you think you or a loved one may have suffered an injury or damages as a result of taking Multaq, you owe it to yourself to speak to an experienced pharmaceutical or drug attorney to see if you have a case and to discuss the possibility of bringing a lawsuit to recover for your damages and injuries. The attorney will be able to ascertain if you have a claim for which a lawsuit can be pursued and whether the case and lawsuit can be brought to a successful settlement, verdict, award or other recovery, and the experienced lawyer will be able to advise you on any deadlines for bringing your legal claim for damages. Please contact the law firm of Ashcraft & Gerel, LLP to discuss your case with an experienced pharmaceutical or drug lawyer in our Drug Litigation Department.

The lawyers at Ashcraft and Gerel, LLP have been leaders in pursuing lawsuits involving unsafe drugs and medical devices. Our attorneys have successfully brought about verdicts, settlements, awards or other recoveries in lawsuits on behalf of clients who have been injured by Fen-Phen, Rezulin, Propulsid, Gadolinium, Ortho Evra, Vioxx, Phenylpropanolamine (PPA), and many other drugs and medical devices. We have a toll free number to reach an attorney to answer your questions with regard to your specific case. That number is 1-800-829-7037. Please ask to speak to Robert Samet, and he will place you in touch with one of our Multaq lawyers. If you would prefer, please feel free to fill out the “Contact Us” form on the left side of this page or email us. Please be sure to include your name, address, telephone number (if you wish to be called), email address and the exact nature of your question, so that our lawyer can provide you with the specific information you seek about Multaq lawsuits.

© Copyright 2012 Ashcraft and Gerel, LLP.
Lawyer SEO by The Search Ninjas.